Can a Parkinson’s Brain Actually Heal?
When someone is diagnosed with Parkinson’s, they’re almost always handed the same story: it’s progressive, it’s neurodegenerative, and the best you can do is manage the decline. I don’t tell my patients to stop their standard Parkinson’s medications. They can genuinely help. But after more than 40 years practicing functional neuropsychiatry, I’ve come at this disease from a different angle, and what I’ve seen in my own patients tells a different story than the one most people are given.
I recently hosted a talk walking through this in depth. You can watch the full presentation here:
Start with root causes, not just symptoms
Parkinson’s is a disease of the dopamine-producing neurons, especially in a part of the brain called the substantia nigra. The question worth asking is why those neurons are degrading in the first place.
Two things show up again and again: chronic inflammation and toxic exposure. There’s good evidence that inflammation is pivotal to the disease process itself, not just a side effect of it, and it’s often driven by hidden chronic infections or long-term exposure to environmental toxins. Pesticides are directly toxic to dopamine neurons. Heavy metals like mercury bind to a protein called tubulin, which is essentially the building block neurons use to grow new branches. When mercury gets in the way, the brain can’t build.
None of this happens in isolation, either. Genetics load the gun, but it’s usually the environment that pulls the trigger. If we want to slow or stop the disease, we have to go looking for what’s actually driving the inflammation in that particular person, not just treat the symptoms it leaves behind.
A pathway standard neurology often skips: thiamine
There’s a specific metabolic pathway in Parkinson’s that rarely gets addressed in conventional care. Dr. Antonio Costantini, who treated over 2,500 Parkinson’s patients with long-term, high-dose thiamine (vitamin B1) injections, documented real improvement, roughly a 50% improvement in both motor symptoms (tremor, balance, initiating movement) and non-motor symptoms within about three months, with the improvement holding steady over time. Some patients with mild Parkinson’s saw a complete clinical recovery.
This isn’t a replacement for standard treatment. But it’s a pathway that’s almost never explored, and in my experience it can make a real difference.
Giving the brain energy: photobiomodulation
To heal, the brain needs energy. We start by mapping it with quantitative EEG (QEEG), which shows us exactly which networks are struggling and how information is (or isn’t) flowing between them.
From there we use targeted laser therapy, far stronger than the light therapy helmets on the market (we’re talking up to 30 watts, versus roughly half a watt in most consumer devices). It’s painless. It increases blood flow, boosts cellular energy, reduces inflammation, and helps clear out the misfolded proteins and cellular debris that build up in a degenerating brain. There’s also a double-blind, placebo-controlled trial published in a mainstream neurology journal showing meaningful improvement on the standard Parkinson’s motor scale, which lines up with what we see in our own patients.
What healing can actually look like
I want to be careful here. This is early, and it’s not yet the large, controlled study I’d want before making sweeping claims. But I’ve seen results like this in a couple of patients now, and I want to share one because it changed how I think about what’s possible.
A 61-year-old woman came to me with tremors so severe she couldn’t operate her car’s turn signal. A Neuroquant MRI, which measures actual brain volume, showed her overall gray matter in the 19th percentile, meaning 80% of people her age had more brain volume than she did. The pallidum, a structure closely tied to movement, was in the 24th percentile.
After two years of functional medicine work, including hyperbaric oxygen and targeted neuro-technologies, her gray matter had grown into the 40th percentile, solidly normal range. Her pallidum grew to the 38th percentile. Her tremors disappeared. She could drive again.
We’re now working toward an IRB approval to study this more formally and in a larger group. I don’t want to overpromise based on one story. But I’ve been doing this long enough to know that this kind of change isn’t supposed to happen, and it did.
The message I want people to hear
Patients come to me terrified that decline is inevitable. I understand why. That’s the story most of us are told. But when you go looking for the actual biological drivers, chronic infection, toxic load, nutrient pathways, energy deficits in specific brain networks, and you address those directly, the brain has more capacity to recover than we usually give it credit for.
I’m not suggesting anyone stop the treatments that are working for them. I’m suggesting there’s more available than most people realize, and that a Parkinson’s diagnosis doesn’t have to mean resigning yourself to getting steadily worse.
If you or someone you love is navigating this, I want you to know there’s real reason for hope.